MOESM3 of Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial

Additional file 3: Table S3. Analysis of covariance on the change from baseline of LBM (g) at week 52 (Efficacy set).